These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28919989)

  • 41. PD1
    Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
    J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PD-1 modulating Mycobacterium tuberculosis-specific polarized effector memory T cells response in tuberculosis pleurisy.
    Li J; Jin C; Wu C; Huang J
    J Leukoc Biol; 2019 Sep; 106(3):733-747. PubMed ID: 30861206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.
    Reiser J; Banerjee A
    J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8
    Li J; Lee Y; Li Y; Jiang Y; Lu H; Zang W; Zhao X; Liu L; Chen Y; Tan H; Yang Z; Zhang MQ; Mak TW; Ni L; Dong C
    Immunity; 2018 Apr; 48(4):773-786.e5. PubMed ID: 29625896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
    Waeckerle-Men Y; Starke A; Wüthrich RP
    Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity.
    Hoover SK; Barrett SK; Turk TM; Lee TC; Bear HD
    Cancer Immunol Immunother; 1990; 31(2):121-7. PubMed ID: 2138931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells.
    Masson F; Calzascia T; Di Berardino-Besson W; de Tribolet N; Dietrich PY; Walker PR
    J Immunol; 2007 Jul; 179(2):845-53. PubMed ID: 17617575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on the minimum requirements for in vitro "cure" of tumor cells by cytotoxic T lymphocytes.
    Miki S; Ksander B; Streilein JW
    Reg Immunol; 1992; 4(6):352-62. PubMed ID: 1297406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Importance of signaling via the IFN-alpha/beta receptor on host cells for the realization of the therapeutic benefits of cyclophosphamide for mice bearing a large MOPC-315 tumor.
    Mokyr MB; Place AT; Artwohl JE; Valli VE
    Cancer Immunol Immunother; 2006 Apr; 55(4):459-68. PubMed ID: 15965646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholesterol Induces CD8
    Ma X; Bi E; Lu Y; Su P; Huang C; Liu L; Wang Q; Yang M; Kalady MF; Qian J; Zhang A; Gupte AA; Hamilton DJ; Zheng C; Yi Q
    Cell Metab; 2019 Jul; 30(1):143-156.e5. PubMed ID: 31031094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modeling tumor immunity of mouse glioblastoma by exhausted CD8
    Nakashima H; Alayo QA; Penaloza-MacMaster P; Freeman GJ; Kuchroo VK; Reardon DA; Fernandez S; Caligiuri M; Chiocca EA
    Sci Rep; 2018 Jan; 8(1):208. PubMed ID: 29317703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Herpes Simplex Virus Latency-Associated Transcript Gene Is Associated with a Broader Repertoire of Virus-Specific Exhausted CD8+ T Cells Retained within the Trigeminal Ganglia of Latently Infected HLA Transgenic Rabbits.
    Srivastava R; Dervillez X; Khan AA; Chentoufi AA; Chilukuri S; Shukr N; Fazli Y; Ong NN; Afifi RE; Osorio N; Geertsema R; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2016 Apr; 90(8):3913-3928. PubMed ID: 26842468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reconstitution of CD8+ T cells by retroviral transfer of the TCR alpha beta-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte.
    Tahara H; Fujio K; Araki Y; Setoguchi K; Misaki Y; Kitamura T; Yamamoto K
    J Immunol; 2003 Aug; 171(4):2154-60. PubMed ID: 12902522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of age-associated exhausted CD8⁺ T cells defined by increased expression of Tim-3 and PD-1.
    Lee KA; Shin KS; Kim GY; Song YC; Bae EA; Kim IK; Koh CH; Kang CY
    Aging Cell; 2016 Apr; 15(2):291-300. PubMed ID: 26750587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.
    Ha D; Tanaka A; Kibayashi T; Tanemura A; Sugiyama D; Wing JB; Lim EL; Teng KWW; Adeegbe D; Newell EW; Katayama I; Nishikawa H; Sakaguchi S
    Proc Natl Acad Sci U S A; 2019 Jan; 116(2):609-618. PubMed ID: 30587582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model.
    Wu Y; Deng Z; Wang H; Ma W; Zhou C; Zhang S
    BMC Immunol; 2016 Sep; 17(1):29. PubMed ID: 27645787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
    Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
    Front Immunol; 2018; 9():583. PubMed ID: 29623079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.